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AbstrAct
 The maxilla rarely undergoes necrosis due to its rich vascularity.  Maxillary necrosis can occur due to bacterial infectio-
ns such as osteomyelitis, viral infections such as herpes zoster or fungal infections such as mucormycosis, aspergillosis 
etc.  Mucormycosis is an opportunistic fulminant fungal infection, which mainly infects immunocompromised patients. 
The infection begins in the nose and paranasal sinuses due to inhalation of fungal spores. The infection can spread to 
orbital and intracranial structures either by direct invasion or through the blood vessels. The fungus invades the arteries 
leading to thrombosis that subsequently causes necrosis of hard and soft tissues. We report a case of maxillary necrosis 
by mucormycosis in an uncontrolled diabetic patient to emphasize early diagnosis of this potentially fatal fungal in-
fection. We briefly discuss different diseases which can lead to maxillary necrosis and review the current concepts in 
management of mucormycosis. Early diagnosis and prompt treatment can reduce the mortality and morbidity of this 
lethal fungal infection.
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INtrODUctION
Mucormycosis is one of the most rapidly progressing and 
lethal form of fungal infection in humans which usually 
begins in the nose and paranasal sinuses (1). This fungus 
invades the arteries, forms thrombi within the blood vessels 
that reduce blood supply and cause necrosis of hard and soft 
tissues (1,2). Once entered into the arteries, the fungus can 
spread to orbital and intracranial structures (3,4). Usually 
mucormycosis presents as an acute infection and manifests 
as rhinocerebral, pulmonary, gastrointestinal, cutaneous 
or disseminated form (1). In the case presented here the 
infection followed a chronic course, and somewhat indolent 
form which eventually caused maxillary necrosis.
cAsE rEPOrt
A man of 58 years reported for evaluation of pain in the 
right maxillary posterior region since 4 months previously. 
Pain was moderate in nature, aggravated on bending the 
head and chewing food. The patient also complained of 
nasal congestion and headache. There was no history of 
fever, purulent discharge, paraesthesia or foul odor.
The patient had undergone extraction of right maxillary 
first, second and third molars 6 months earlier due to 
poor periodontal health. Following extractions the socket 
never healed completely.  Patient had persistent pain and 
discomfort for the last 6 months.
The patient was a known diabetic on treatment with oral 
hypoglycemics for the last 10 years. He had been under 
medical supervision for the first 3 years (Tab. PIO-G, Indi 
pharma). However, he continued the same medication (Pa-
tient also took ayurvedic/ herbal medications) for the last 
7 years without consulting a physician or undergoing any 
routine blood sugar estimation. Due to financial constrains 
the patient did not take the medication as per the prescribed 
dose and avoided laboratory investigations.
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On general examination vital signs were within normal 
limits. Intraoral oral examination showed a necrotic bone 
of about 1 cm diameter in right maxillary molar region 
(fig-1). Maxillary molars were missing and surrounding 
soft tissues were normal.  
A radiograph (paranasal sinus view) was advised that 
showed haziness of right maxillary sinus with erosion of 
lateral sinus wall (fig-2). CT scan was not performed due 
to financial constrains. Biochemical investigations revealed 
an elevated blood sugar levels. Fasting blood sugar was 238 
mg/dl (normal 60-90 mg/dl) & post prandial blood sugar 
level was 386 mg/dl (normal 90-140 mg/dl). A biopsy was 
advised. Hard tissue specimen along with the adjacent 
soft tissue was excised under local anesthesia and sent for 
histopathological examination. 
Histopathological examination with hematoxylin and eosin stain 
readily identified non-septate mucormycotic hyphae. Grocott’s 
modified silver methenamine special staining technique further 
identified these non-septate branching hyphae of mucormycosis 
(fig 3). The culture report was non contributory.
The patient was hospitalized and physicians controlled 
blood sugar levels with insulin. The necrotic bone along 
with 1 cm of  adjacent bone was excised under general 
anesthesia. The patient was administered Amphotericin-B 
0.8mg/kg/day intravenously for two weeks. It was slowly 
infused over 4-6 hours and blood urea and creatinine levels 
were monitored as the drug can cause renal toxicity. Two 
weeks later the area started healing and subsequently after 
three months an obturator was made for the patient.
 
DIscUssION 
Opportunistic fungal infections such as mucormycosis 
usually occur in immunocompromised patients but can 
infect healthy individuals as well(2-5). The predisposing 
factors for mucormycosis are uncontrolled diabetes (parti-
cularly in patients having ketoacidosis), malignancies such as 
lymphomas and leukemia’s, renal failure, organ transplant, 
long term corticosteroid and immunosuppressive therapy, 
cirrhosis, burns, protein energy malnutrition and AIDS. Our 
patient had uncontrolled diabetes which is a well known 
predisposing factor for mucormycosis(1-8).
Mucormycosis (Zygomycosis, phycomycosis) is an acute 
opportunistic infection caused by a saprophytic fungus 
that belongs to the class of phycomycetes. Although several 
genera are associated with this disease, the most common 
forms are Rhizopus, Rhizomucor and Absida. Rhizopus is 
the predominant pathogen accounting for 90% of the cases 
of rhinocerebral mucormycosis. This microbe may be cultu-
red from the oral cavity, nasal passages, throat and stool of 
healthy patients without clinical signs of infection. 
Uncontrolled diabetes mellitus can alter the normal immu-
nologic response of patients to infections. Such patients have 
decreased granulocyte phagocytic ability with altered poly-
morphonuclear leukocyte response. Reports have suggested 
that the ability of serum of immunocompromised patients 
to inhibit Rhizopus invitro is reduced, which makes them 
suitable hosts to opportunistic fungal infections(8).
Fig. 1. Intra oral photograph showing necrosis of the right maxillary 
alveolar bone.
Fig. 2. Water’s view showing haziness of both maxi-
llary sinus with erosion in the lateral wall of right 
maxillary sinus. 
Fig. 3. Non septate mucormycotic hyphae observed under Grocott’s 
modified silver methenamine staining technique.
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This fungal infection usually originates from the paranasal 
sinuses. The fungus invades the blood vessels and subse-
quently spreads through them. Once fungal hyphae enter 
into the blood stream they can disseminate to other organs 
such as cerebrum or lungs which can be fatal for the patient. 
Mucor hyphae form thrombi within the blood vessels that 
reduce vascularity to the tissues and cause necrosis(2-5,8). 
Peripheral vascular disease (due to microangiopathy & 
atherosclerosis) in diabetic patients also causes local tissue 
ischemia and increased susceptibility to infections (9) (Table 
1). Therefore thrombosis of the internal maxillary artery 
or descending palatine artery caused by mucormycotic 
infection(4) as well as chronic diabetes in this patient had 
resulted in necrosis of the maxilla.
Usually mucormycosis  occurs as a pulmonary, 
gastrointestinal, disseminated or rhinocerebral infec-
tion(6-10). In our patient, infection was only localized to 
the maxilla and it underwent necrosis without any other 
symptoms. Disseminated involvement of mucormycosis is 
observed in diabetics with ketoacidosis, which favors rapid 
proliferation of fungus and its invasion into the orbit and 
cerebrum(6). Mucormycosis is aggressive and potentially 
fatal in diabetic patients because of impaired host defense 
mechanism and increased availability of micronutrients such 
as iron(9). The general health of this patient was good and 
he did not developed ketoacidosis which facilitates spread of 
infection to other organ systems. Therefore, in this case the 
patient had a localized rhino-maxillary form of the disease 
which is a subdivision of well documented rhinocerebral 
mucormycosis (10,11). However the infection may spread 
to involve the cranium, orbit and other organs. Therefore, 
a team of specialists including a dentist, ophthalmologist, 
neurosurgeon and maxillofacial surgeon are required for 
management of such patients.
In the early stages of  the disease, patients exhibit facial 
cellulites, anesthesia, nasal discharge, necrotic turbinates, 
fever, headache and lethargy(6). However, in contrast to 
other reports many of these symptoms were absent in this 
patient. He only had nasal congestion and headache.
Among the clinical differential diagnosis we can consider 
squamous cell carcinoma of maxillary sinus. Such cases 
present as chronic ulcers with raised margins causing expo-
sure of underlying bone. A malignant salivary gland tumor 
arising from the accessory glands of the palate can also 
be considered in the differential diagnosis. Other features 
seen in cases of antral carcinoma are local pain, swelling, 
epistaxis, nasal discharge, epiphora, diplopia or numbness. 
In this patient there were no symptoms suggestive of any 
malignancy.
Extranodal NK T-cell lymphoma (nasal type angiocentric 
lymphoma or midline lethal granuloma) characteristically 
occurs in midline, affecting the oronasal region. In the initial 
stages patients may report nasal stuffiness, pain and palatal 
swelling. Later, patients develop progressive areas of ulcera-
tion that can lead to bone necrosis and perforation.
Wegener’s granulomatosis is an uncommon condition cha-
racterized by a necrotizing granulomatous condition of 
respiratory tract, widespread vasculitis and necrotizing glo-
merulonephritis. Common presenting signs and symptoms 
include sinusitis, rhinorrhea, nasal stuffiness and epistaxis 
with or without complain of fever, arthralgia and weight 
loss. Gingiva has a peculiar erythematous hyperplasia and 
is termed strawberry gingivitis. There may be destruction 
of underlying palatal and alveolar bone causing oral-antral 
fistula.
Bone necrosis can also occur due to extension of infections 
such as acute necrotizing ulcerative gingivitis (ANUG) from 
the gingiva to bone. In the case reported here the gingiva 
was normal. Recent reports have suggested that jaw necrosis 
can also occur in patients on bisphosphonate therapy(12). 
Our patient did not report any such drug intake. 
There is a close histopathological resemblance between mu-
cormycosis and aspergillosis.  Microscopically, aspergillosis 
has septate branching hyphae, which can be distinguished 
from mucormycotic hyphae by a smaller width and promi-
nent acute angulations of branching hyphae(9,10).  Mo-
reover, the organism produces conidiophores, which were 
absent in this case. A definitive diagnosis of mucormycosis 
can be made by tissue biopsy that identifies the characteristic 
hyphae, by positive culture or both. Initial culture of disea-
sed tissue may be negative and histopathologic examination 
is essential for early diagnosis(9) In this case, the fungus was 
identified by hematoxylin and eosin stain and confirmed by 
Grocott’s silver methenamine special staining technique.
Three principles in the patient management were followed. 
Firstly, control of diabetes for which the patient was advised 
insulin therapy and dietary restrictions. Secondly, removal 
of the necrotic bone, which acted as a nidus of infection and 
prevented action of systemically, administered antifungal 
drugs (due to thrombosis of blood vessels).  In this patient 
entire necrotic bone was removed along with the antral 
lining and the area was débrided with Betadine.  Lastly, am-
photericin B was administered parenterally as it is the drug 
of choice in treatment of mucormycotic infection(2,5,10). 
Blood urea & creatinine levels were monitored. Post-opera-
tively patient was advised an obturator to prevent oronasal 
regurgitation. 
Mucormycosis was long regarded as a fatal infection with 
poor prognosis. However with early medical and surgical 
management survival rates are now thought to exceed 
80%(5). This patient survived because of an early diagnosis 
and prompt treatment.
In conclusion, an immunocompromised or immunosu-
ppressed patient having bone necrosis following tooth ex-
traction should alert a clinician of possible mucormycotic 
infection.
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table 1. Showing the pathophysiology of bone necrosis secondary to mucormycotic infection in a diabetic patient.






Decreased immunity Microangiopathy & 
atherosclerosis 
Fungus invades from the 
sinus into blood vessels 




Invade more vessels  
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